TKIs in Sarcoma
Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

Released: November 02, 2021

Jean Yves Blay
Jean Yves Blay, MD, PhD
Robin L. Jones
Robin L. Jones, BSc, MBBS, MRCP, MD (Res)

Activity

Progress
1
Course Completed
In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss the most important clinical trial data on leveraging TKIs as monotherapy and in combination with chemotherapy or immune checkpoint inhibitors for treatment of soft tissue sarcoma and osteosarcoma.